Deep Breeze(TM), the leader in vibration response imaging (VRI(TM)) technology, today announced that the U.S. Food and Drug Administration (FDA) granted 510K marketing clearance for the VRIXP(TM), a non-invasive, radiation-free pulmonary imaging system to use lung sounds to create dynamic images of the lungs.
"Vibration response imaging enables physicians to effectively record and monitor lung sounds with the ultimate goal of improving the detection and assessment of lung disorders in the future," said Igal Kushnir, MD, President and CEO of Deep Breeze(TM). "FDA clearance represents a significant milestone for the Company and we plan to work closely with U.S. interventional pulmonologists to bring this advanced pulmonary imaging system to patients suffering from lung disorders."
FDA Clears Unique Non-Invasive, Radiation-Free Pulmonary Imaging System
0 comments :
Post a Comment